NEW YORK (GenomeWeb) – The National Cancer Institute and US Food and Drug Administration said today they have signed a memorandum of understanding to collaborate on proteogenomic cancer research.

According to the agencies, the MOU will allow them "to share information that will accelerate the development of proteogenomic technologies and biomarkers, as it relates to precision medicine in cancer."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.